Suchergebnisse - "Rodriguez-Abreu, Delvys"

PubPharm (122)

1

Pembrolizumab Plus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1% : Pooled Analysis of Outcomes After 5 Years of Follow-Up

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Gadgeel, S. | Rodríguez-Abreu, D. | Halmos, B. | +7

2

Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer : KEYNOTE-782

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Bar, J. | Esteban, E. | Rodríguez-Abreu, D. | +20

3

Describing differences among populations of thoracic tumors patients under and over 80 years : Data analysis from the SLCG thoracic tumor registry

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Provencio, M. | Cobo, M. | Rodriguez-Abreu, D. | +20

4

The state of the art of EGFR exon 20 insertions in non-small cell lung cancer : Diagnosis and future perspectives

enthalten in: Cancer treatment reviews | 2024

von Dorta-Suárez, M. | de Miguel, M. | Amor-Carro, O. | +3

5

The S-REAL study : Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Gómez Rueda, A. | Taus, �. | Álvarez Álvarez, R. | +37

6

Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients

enthalten in: Archivos de bronconeumologia | 2024

von Candal-Pedreira, C. | Ruano-Ravina, A. | Calvo de Juan, V. | +21

7

Difficulties on the access to innovative targeted therapies for lung cancer in Spain

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Calvo, V. | Camps, C. | Carcereny, E. | +13

8

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Provencio-Pulla, M. | Pérez-Parente, D. | Olson, S. | +9

9

STAR-121 : A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations

enthalten in: Clinical lung cancer | 2024

von Rodriguez-Abreu, D. | Bosch-Barrera, J. | Gray, J. | +8

10

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Weiss, S. | Sznol, M. | Shaheen, M. | +14

CommentIn: Clin Cancer Res. 2024 Jan 5;30(1):9-11. - PMID 37870487

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]